Evidence map›Paper›PMID 19622764›Full record

ArticleCancer research2009

Host-derived tumor endothelial marker 8 promotes the growth of melanoma.

Mike Cullen, Steven Seaman, Amit Chaudhary, Mi Young Yang, Mary Beth Hilton, Daniel Logsdon, Diana C Haines, Lino Tessarollo, Brad St Croix

Open access · hybridAbstract read
In one paragraph

Article in Cancer research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. GAPO syndrome with craniosynostosis and intracranial hypertension.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2019
    Article
  13. Review
  14. Article
  15. Review
  16. Frontiers in medicine · 2019
    Article
  17. Structural basis for anthrax toxin receptor 1 recognition by Seneca Valley Virus.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mike CullenTumor Angiogenesis Section, Mouse Cancer Genetics Program, Science Applications International Corporation, National Cancer Institute-Frederick, Frederick, Maryland 21702-1201, USA.
Steven Seaman
Amit Chaudhary
Mi Young Yang
Mary Beth Hilton
Daniel Logsdon
Diana C Haines
Lino Tessarollo
Brad St Croix
Cancer Genetics (United States) · USScience Applications International Corporation (United States) · US

Funding

Functional Analysis of TEM5 and TEM8ZIABC010484 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ST CROIX, BRADLEY D · 2009 to 2025
$9.3M
Functional Analysis of TEM5 and TEM8Z01BC010484 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ST CROIX, BRADLEY D · 2003 to 2008
$529k
CCR NIH HHS HHSN261200800001CIntramural NIH HHS Z01 BC010484NCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

Tumor endothelial marker 8 (TEM8) was initially identified as a gene overexpressed in the vasculature of human tumors and was subsequently identified as an anthrax toxin receptor. To assess the functional role of TEM8, we disrupted the TEM8 gene in mice by targeted homologous recombination. TEM8(-/-) mice were viable and reached adulthood without defects in physiologic angiogenesis. However, histopathologic analysis revealed an excess of extracellular matrix in several tissues, including the ovaries, uterus, skin, and periodontal ligament of the incisors, the latter resulting in dental dysplasia. When challenged with B16 melanoma, tumor growth was delayed in TEM8(-/-) mice, whereas the growth of other tumors, such as Lewis lung carcinoma, was unaltered. These studies show that host-derived TEM8 promotes the growth of certain tumors and suggest that TEM8 antagonists may have utility in the development of new anticancer therapies.

Indexed as

AnimalsBiomarkers, TumorCarcinoma, Lewis LungFemaleMaleMelanoma, ExperimentalMiceMice, Inbred C57BLMice, KnockoutMicrofilament ProteinsNeovascularization, PathologicReceptors, Cell SurfaceReceptors, PeptideAntxr1 protein, mouseBiomarkers, TumorMicrofilament ProteinsReceptors, Cell SurfaceReceptors, Peptide

Identifiers

PMID19622764
PMCPMC2721800
OpenAlexW2131628918

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.